glp-1 receptor agonist antipsychotic weight gain study The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials Antipsychotic Weight Gain and Metabolic
Description
Most patients tolerate the medications well after the initial adjustment period
Drugs that suppress appetite will have a huge impact on multiple markets if they deliver on current expectations
doi: 10.1177/2042098612446473
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Bush M, Scott R, Watanalumlerd P, Zhi H, Lewis E
GLP-1 receptor agonists, including liraglutide and semaglutide, demonstrate neuroprotective effects by modulating neuroinflammation and pathways related to neuronal survival [14]
10.1056/NEJMoa1307684 172 SestiG.AvogaroA.BelcastroS.BonoraB
